Table 1.
Age and sex distribution of 427 participants
| Age in years |
Sickle Cell Disease Cases n=357 |
HbAA Controls n=70 |
Total | |||
| Male n (%) | Female n (%) | Male n (%) | Female n % | Male n (%) | Female n (%) | |
| 1<2 | 7 (2.0) | 2 (0.6) | 10 (14.3) | 1 (1.4) | 17 (4.0) | 3 (0.7) |
| 2-<5 | 48 (13.4) | 32 (9.0) | 11 (15.7) | 13 (18.6) | 59 (13.8) | 45 (10.5) |
| 5-<9 | 67 (18.8) | 63 (17.6) | 9 (12.9) | 15 (21.4) | 76 (17.8) | 78 (18.3) |
| 9–12 | 66 (18.7) | 72 (20.1) | 8 (11.4) | 3 (4.3) | 74 (17.3) | 75 (17.6) |
| Total | 188 (52.7) | 169 (47.3) | 38 (54.3) | 32 (45.7) | 226 (52.9) | 201 (47.1) |
| χ2 = 5.3, p=0.147 | χ2 = 12.3, p=0.006 | χ2 = 12.29,p=0.006 | ||||